Olema Pharmaceuticals, Inc. Business Operations Contracts & Agreements
8 Contracts & Agreements
- Collaboration Agreements (5 contracts)
- Indemnification Agreements (1)
- Sales Agreements (2)
- Amendment No. 2 to Amended and Restated Clinical Collaboration and Supply Agreement, by and between the Company and Novartis Institutes for BioMedical Research, Inc., dated March... (Filed With SEC on May 8, 2024)
- Sales Agreement by and between Registrant and Cowen and Company, LLC, dated January 5, 2024 (Filed With SEC on January 5, 2024)
- Amendment No. 1 to Amended and Restated Clinical Collaboration and Supply Agreement, by and between the Company and Novartis Institutes for BioMedical Research, Inc., dated... (Filed With SEC on October 10, 2023)
- Amended and Restated Clinical Collaboration and Supply Agreement, by and between the Registrant and Novartis Institutes for BioMedical Research, Inc., dated January 13, 2022 (Filed With SEC on May 9, 2023)
- Sales Agreement by and between Registrant and Oppenheimer & Co. Inc., dated March 9, 2023 (Filed With SEC on March 9, 2023)
- Drug Discovery Collaboration and License Agreement by and between the Registrant and Aurigene Discovery Technologies Limited, dated June 7, 2022 (Filed With SEC on August 9, 2022)
- Clinical Collaboration and Supply Agreement by and between the Registrant and Novartis Institutes for BioMedical Research, Inc., dated July 22, 2020 (Filed With SEC on October 30, 2020)
- Form of Indemnification Agreement by and between the Registrant and its directors and executive officers (Filed With SEC on October 30, 2020)
